Ulrich Rothbauer,
Professor,
Natural and Medical Sciences Institute at the University of Tuebingen
Ulrich Rothbauer, Ph.D is working on new technologies to study proteins and protein interactions in living cells. His main focus lies on the development of disease relevant assays and target specific nanoprobes for High Content Analysis based on the Chromobody-Technology. Dr. Rothbauer has studied biology at the Ludwig-Maximilians University (LMU). He received his Ph.D in Biochemistry in 2003 revealing the pathomechanism of a mitochondrial disease. After his postdoctoral work on the regulation of the epigenetic keyfactors he became an independent group leader at the LMU-Biocenter in 2006. As a junior group leader he directed R&D projects in a range of cellular diagnostic areas including cell cycle studies, apoptosis studies, proteomics and protein-protein interactions. 2008 he founded the Biotech spin-off company ChromoTek, which develops and commercializes new technologies to perform cellular diagnostics and proteomics. 2011 he became full professor for Pharmaceutical Biotechnology at the University Tuebingen, Germany.
|
|
|